# Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Study · id `cardio:ct-nct03968393` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03968393](<https://clinicaltrials.gov/study/NCT03968393>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03968393

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2270 participants.

## Technical summary

Registry record NCT03968393. Randomized; single masking; primary purpose prevention. Start 2019-06-14 (actual); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 2270 participants (planned count; ClinicalTrials.gov record NCT03968393, source copy `cardio:ctgov-nct03968393-2026-01-12`, retrieved 2026-10-26)
- Started: 2019-06-14 (actual) (ClinicalTrials.gov record NCT03968393, source copy `cardio:ctgov-nct03968393-2026-01-12`, retrieved 2026-10-26)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT03968393, source copy `cardio:ctgov-nct03968393-2026-01-12`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT03968393, source copy `cardio:ctgov-nct03968393-2026-01-12`, retrieved 2026-10-26)
- Countries: United States; Argentina; Australia; Brazil; Canada; Denmark; Finland; Germany; India; Italy; Nepal; Netherlands; Pakistan; South Korea; Spain; Sweden; Switzerland; United Kingdom (ClinicalTrials.gov record NCT03968393, source copy `cardio:ctgov-nct03968393-2026-01-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03968393-2026-01-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- Acronym: ASPIRE-AF
- Condition: Stroke
- Condition: Atrial Fibrillation
- Intervention (Drug): Non-vitamin K oral anticoagulant (NOAC)
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER
- Collaborator: Hamilton Health Sciences Corporation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)
- Registry lists this organization as a collaborator: Hamilton Health Sciences Corporation (`cardio:org-hamilton-health-sciences-corporation`)

## Provenance

Content hash: 6d948720d90d816b95de10506f0b5c3e9a488764b1008d9de619a8a2f38fc070
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
